Kevin Williams, M.D., is the Chief Medical Officer (CMO) for Pfizer Rare Disease. In this role, he leads a Medical Affairs organization of approximately 200 medical colleagues around the globe supporting Pfizer’s efforts and portfolio in Rare Disease. Williams joined Pfizer in January 2004 as a Director of Regional Medical & Research Specialists working in the HIV disease area. After moving into a Team Leader position in July 2005, he has served in various leadership roles during his career at Pfizer.
Williams has been reelected to SAGE’s Board as a regular member, having previously served on the Board for six years, from 2012 to 2018, as the Secretary and Chair of the Nominating and Governance Committee and then Co-Chair.
Williams received his medical degree from the UCLA School of Medicine and is board-certified in internal medicine. Following a two-year fellowship in Health Services Research at UCLA and a brief academic career as an instructor of Medicine at the UCLA School of Medicine, he spent eight years in private practice caring for HIV-positive patients while maintaining an academic appointment at the UCLA School of Medicine as an Assistant Clinical Professor of Medicine.
In addition to his medical degree, he has a Masters in Public Health from the UCLA School of Public Health and a Juris Doctorate from Harvard Law School.